Drug Patents owned by Urogen Pharma

1. List of Jelmyto drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9040074 UROGEN PHARMA Material and method for treating internal cavities
Jan, 2031

(7 years from now)

US9950069 UROGEN PHARMA Material and method for treating internal cavities
Jan, 2031

(7 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Apr 15, 2027
New Product (NP) Apr 15, 2023

Drugs and Companies using MITOMYCIN ingredient

Market Authorisation Date: 15 April, 2020

Treatment: NA

Dosage: POWDER;PYELOCALYCEAL

More Information on Dosage

JELMYTO family patents

8

United States

4

Israel

2

European Union

1

Germany

1

Denmark

1

Spain

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in